However, relapsed neuroblastomas contain higher numbers of recurrent and targetable mutations such as those in ALK (Eleveld et al. 2015; Padovan-Merhar et al. 2016; Schleiermacher et al. 2014; Schramm et al. 2015). This evidence concerns the gene ALK and neuroblastoma.